Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
about
Implications of apixaban for dental treatmentsReport of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF).Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis of 1691 patients.Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation.Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis.Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-AnalysisEfficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.Apixaban, rivaroxaban, and dabigatran use in patients undergoing catheter ablation for atrial fibrillation using the second-generation cryoballoon.Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.The Total Incidence of Complications and the Impact of an Anticoagulation Regime on Adverse Events After Cryoballoon Ablation of Atrial Fibrillation: A Single-Center Study of 409 Patients.Incidence and predictors of pericardial effusion as an early complication of catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF).Use of the CHA2DS2VASc score to reduce utilisation of transoesophageal echocardiography prior to ablation for atrial fibrillationApixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
P2860
Q28079697-F84AC513-8A49-40F4-AB89-3DB0E73CA47CQ33764565-3FC30A8F-0C31-4767-B072-2B21F76F4B2DQ36027550-7246B0AF-0795-4296-A174-2061F3135E20Q36172403-7AAE5FFA-078B-4EB4-9252-081A740E902EQ36240734-875BF5EC-DA92-4CAC-AFF1-E2F8820847F7Q36999959-BA4EBDF6-0D51-49B3-A443-588648A6FB84Q37623666-6CA209F8-D315-4163-A2E4-3219645AFF3FQ38605644-F93D08B6-ED16-48C7-8E29-DEF1BAEFA5EEQ39584450-CA766DF6-3124-4D03-A102-0B9E97347CF2Q39994748-1FE51C06-7455-4ED0-8CEF-C1BA972701EEQ42151028-F475F7C5-7460-4E5E-B426-C7C59356D7C6Q42269593-15542A42-0EC0-407E-9C2C-32A5B30C588EQ48883477-46F430AE-14C9-4ADC-8B9E-D69B0ED4A4D7
P2860
Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Apixaban, Rivaroxaban, and Dab ...... Atrial Fibrillation Ablation.
@en
type
label
Apixaban, Rivaroxaban, and Dab ...... Atrial Fibrillation Ablation.
@en
prefLabel
Apixaban, Rivaroxaban, and Dab ...... Atrial Fibrillation Ablation.
@en
P2093
P2860
P356
P1476
Apixaban, Rivaroxaban, and Dab ...... Atrial Fibrillation Ablation.
@en
P2093
Andreas Metzner
Andreas Rillig
Christian-H Heeger
Christine Lemes
Erik Wissner
Feifan Ouyang
Joaquina Plesman
Peter Wohlmuth
Roland Richard Tilz
Shibu Mathew
P2860
P304
P356
10.1111/JCE.12856
P577
2015-10-14T00:00:00Z